# Technical Methodologies: AI Product Management

This document bridges the gap between high-level macro-management operations and low-level empirical machine learning fundamentals, detailing specific operational parameters required to orchestrate AI platforms.

## 1. Algorithmic Evaluation Metrics (The Precision / Recall Tradeoff)

Standard SaaS product metrics (DAU, Churn) are insufficient for managing machine learning capabilities. In the projects outlined (such as the Medical Capstone), products are evaluated critically on their statistical behavior before user distribution.

- **Precision vs. Recall Indexing**: In healthcare imaging implementations (outlined in the Capstone), False Positives (diagnosing a healthy patient) and False Negatives (missing a terminal condition) carry disproportionate weights. The product requires elevating **Recall** over Precision, intentionally prioritizing higher flag rates to ensure malignant conditions are systematically escalated to a human-in-the-loop clinical environment without bottlenecking the inference time.
- **AUC/ROC Baselines**: Setting minimum threshold acceptance metrics that must be matched in A/B production runs prior to model rollout.

## 2. Distributed Data Annotation Pipelines

The success of any custom internal model is strictly correlated with labeling velocity and accuracy. Within the `/Data Labeling` segment, I explore:

- **Human-in-the-loop (HITL)**: Integrating scalable data labeling pathways. Assigning confidence thresholds natively where `predict_proba < 0.8` routes outputs systematically to structured domain experts for re-annotation.
- **Semi-Supervised Expansion**: Rapidly minimizing annotation budgets by utilizing initial clustered datasets as seeds, applying weak supervision heuristics, and fine-tuning off subsequent epochs.

## 3. Structural Decision Theory: Build vs. Buy

Machine Learning integration rarely necessitates training generalized transformers from scratch. The decision matrix dictates project viability:

- **Evaluating Open-Source Equivalents (Buy)**: Testing baseline constraints against managed APIs (e.g., OpenAI, Anthropic, or specialized medical API vendors). This accelerates MVP (Minimum Viable Product) delivery and significantly offloads immediate DevOps infrastructure management.
- **Monolithic In-House Scaling (Build)**: Assessing the cost tipping-points where API token expenditure outpaces cloud-compute requirements. Focusing structural migrations around isolated fine-tuning pipelines (ex: parameter-efficient models via LoRA on LLama) and safeguarding highly proprietary data outside third-party exposure limits. 

## 4. Mitigating Concept Drift & Model Safety

A predictive model decays the moment it enters production. Strategies included within the repository detail ongoing operational safety:
- Generating dynamic inference logs.
- Scheduling automated retraining epochs based on historical decay gradients rather than fixed temporal schedules. 
- Structuring feedback loops directly within the client UX to continually pipe verified labels back into the storage layer.
